242 related articles for article (PubMed ID: 28368674)
21. mPEG-PAMAM-G4 nucleic acid nanocomplexes: enhanced stability, RNase protection, and activity of splice switching oligomer and poly I:C RNA.
Reyes-Reveles J; Sedaghat-Herati R; Gilley DR; Schaeffer AM; Ghosh KC; Greene TD; Gann HE; Dowler WA; Kramer S; Dean JM; Delong RK
Biomacromolecules; 2013 Nov; 14(11):4108-15. PubMed ID: 24164501
[TBL] [Abstract][Full Text] [Related]
22. Atomic level insights into realistic molecular models of dendrimer-drug complexes through MD simulations.
Jain V; Maiti PK; Bharatam PV
J Chem Phys; 2016 Sep; 145(12):124902. PubMed ID: 27782646
[TBL] [Abstract][Full Text] [Related]
23. Binding free energy calculations using MMPB/GBSA approaches for PAMAM-G4-drug complexes at neutral, basic and acid pH conditions.
Martínez-Muñoz A; Bello M; Romero-Castro A; Rodríguez-Fonseca RA; Rodrigues J; Sánchez-Espinosa VA; Correa-Basurto J
J Mol Graph Model; 2017 Sep; 76():330-341. PubMed ID: 28759825
[TBL] [Abstract][Full Text] [Related]
24. Interaction between PAMAM-NH₂ G4 dendrimer and 5-fluorouracil in aqueous solution.
Buczkowski A; Sekowski S; Grala A; Palecz D; Milowska K; Urbaniak P; Gabryelak T; Piekarski H; Palecz B
Int J Pharm; 2011 Apr; 408(1-2):266-70. PubMed ID: 21335079
[TBL] [Abstract][Full Text] [Related]
25. Transcorneal iontophoresis of dendrimers: PAMAM corneal penetration and dexamethasone delivery.
Souza JG; Dias K; Silva SA; de Rezende LC; Rocha EM; Emery FS; Lopez RF
J Control Release; 2015 Feb; 200():115-24. PubMed ID: 25553828
[TBL] [Abstract][Full Text] [Related]
26. [PEGylated polyamidoamine dendrimer/methotrexate complex: pharmacokinetics and anti-tumor activity in normal and tumor-bearing rodents].
Kong SY; Tang GT; Pei YY; Jiang YY
Yao Xue Xue Bao; 2009 Jan; 44(1):85-90. PubMed ID: 19350828
[TBL] [Abstract][Full Text] [Related]
27. Targeting Breast Cancer Cells with G4 PAMAM Dendrimers and Valproic Acid Derivative Complexes.
Muñoz AM; Fragoso-Vázquez MJ; Martel BP; Chávez-Blanco A; Dueñas-González A; R García-Sánchez J; Bello M; Romero-Castro A; Correa-Basurto J
Anticancer Agents Med Chem; 2020; 20(15):1857-1872. PubMed ID: 32324521
[TBL] [Abstract][Full Text] [Related]
28. PEGylated polyamidoamine dendrimers with bis-aryl hydrazone linkages for enhanced gene delivery.
Yuan Q; Yeudall WA; Yang H
Biomacromolecules; 2010 Aug; 11(8):1940-7. PubMed ID: 20593893
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, biodistribution, and imaging of PEGylated-acetylated polyamidoamine dendrimers.
Liu J; Liu J; Chu L; Tong L; Gao H; Yang C; Wang D; Shi L; Kong D; Li Z
J Nanosci Nanotechnol; 2014 May; 14(5):3305-12. PubMed ID: 24734545
[TBL] [Abstract][Full Text] [Related]
30. Complexation between α-cyclodextrin and PEGylated-PAMAM dendrimers at low and high pH values.
Khouri S; Tam KC
Langmuir; 2010 Dec; 26(23):17969-74. PubMed ID: 21038877
[TBL] [Abstract][Full Text] [Related]
31. Multifunctional lactobionic acid-modified dendrimers for targeted drug delivery to liver cancer cells: investigating the role played by PEG spacer.
Fu F; Wu Y; Zhu J; Wen S; Shen M; Shi X
ACS Appl Mater Interfaces; 2014 Sep; 6(18):16416-25. PubMed ID: 25185074
[TBL] [Abstract][Full Text] [Related]
32. In vitro enzymatic stability of dendritic peptides.
Yang H; Lopina ST
J Biomed Mater Res A; 2006 Feb; 76(2):398-407. PubMed ID: 16270346
[TBL] [Abstract][Full Text] [Related]
33. Poly(amido amine) dendrimers as absorption enhancers for oral delivery of camptothecin.
Sadekar S; Thiagarajan G; Bartlett K; Hubbard D; Ray A; McGill LD; Ghandehari H
Int J Pharm; 2013 Nov; 456(1):175-85. PubMed ID: 23933439
[TBL] [Abstract][Full Text] [Related]
34. Partial Surface Modification of Low Generation Polyamidoamine Dendrimers: Gaining Insight into their Potential for Improved Carboplatin Delivery.
Nguyen DH; Bach LG; Nguyen Tran DH; Cao VD; Nguyen TNQ; Le TTH; Tran TT; Thi TTH
Biomolecules; 2019 Jun; 9(6):. PubMed ID: 31159469
[TBL] [Abstract][Full Text] [Related]
35. Breast Tumor Targeting with PAMAM-PEG-5FU-
Narmani A; Arani MAA; Mohammadnejad J; Vaziri AZ; Solymani S; Yavari K; Talebi F; Darzi SJ
Biomed Microdevices; 2020 Apr; 22(2):31. PubMed ID: 32335724
[TBL] [Abstract][Full Text] [Related]
36. Biotin functionalized PEGylated poly(amidoamine) dendrimer conjugate for active targeting of paclitaxel in cancer.
Rompicharla SVK; Kumari P; Bhatt H; Ghosh B; Biswas S
Int J Pharm; 2019 Feb; 557():329-341. PubMed ID: 30599231
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and evaluation of pegylated dendrimeric nanocarrier for pulmonary delivery of low molecular weight heparin.
Bai S; Ahsan F
Pharm Res; 2009 Mar; 26(3):539-48. PubMed ID: 19034631
[TBL] [Abstract][Full Text] [Related]
38. Inclusion complexes of isoflavones with two commercially available dendrimers: Solubility, stability, structures, release behaviors, cytotoxicity, and anti-oxidant activities.
Zhao C; Wang Y; Su Y; Zhang H; Ding L; Yan X; Zhao D; Shao N; Ye X; Cheng Y
Int J Pharm; 2011 Dec; 421(2):301-9. PubMed ID: 22001794
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of polyamidoamine dendrimers as potential carriers for quercetin, a versatile flavonoid.
Madaan K; Lather V; Pandita D
Drug Deliv; 2016; 23(1):254-62. PubMed ID: 24845475
[TBL] [Abstract][Full Text] [Related]
40. Influence of dendrimer generation and polyethylene glycol length on the biodistribution of PEGylated dendrimers.
Kojima C; Regino C; Umeda Y; Kobayashi H; Kono K
Int J Pharm; 2010 Jan; 383(1-2):293-6. PubMed ID: 19761822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
